Abhijit S. Naik

University of Michigan

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (22)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Collaborators (11)

Paul Palevsky

Professor

University of Pittsburgh

UNITED STATES

View details

Guanshi Zhang

Assistant Professor/Research

University of Texas Health Science Center at San Antonio

UNITED STATES

View details

James M. Pipas

University of Pittsburgh

UNITED STATES

View details

Jonathan Segal

University of Michigan

UNITED STATES

View details

Lihua Li

Mount Sinai Hospital

UNITED STATES

View details

Jens Hansen

Icahn School of Medicine at Mount Sinai

UNITED STATES

View details

Matthew Cusick

HLA Director/ Assistant Professor

University of Michigan

UNITED STATES

View details

Ulysses Balis

University of Michigan

UNITED STATES

View details

Markus Bitzer

University of Michigan

UNITED STATES

View details

Tara Sigdel

University of California, San Francisco

UNITED STATES

View details

Steven Menez

Assistant Professor of Medicine

Johns Hopkins University School of Medicine

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Abhijit S. Naik

Research Interests

Explore related searches

Contact this professor

Articles (22)

Assessing health care disparities in US organ procurement organizations

The growth hormone/IGF-1 axis is a risk factor for long-term kidney allograft failure

Perioperative Acute Kidney Injury: Diagnosis, Prediction, Prevention, and Treatment

Gene Expression Sets and Renal Profiling from the Renal AL Amyloid Involvement and NEOD00 (RAIN) Trial

Rationale and Design of a Phase 2, Double-blind, Placebo-Controlled, Randomized Trial Evaluating AMP Kinase-Activation by Metformin in Focal Segmental Glomerulosclerosis

APOL1 Kidney Risk Variants and Long-Term Kidney Function in Healthy Middle-Aged Black Individuals: The Atherosclerosis Risk in Communities (ARIC) Study

COMPOSITE SCORES FOR TRANSPLANT CENTER EVALUATION: A NEW INDIVIDUALIZED EMPIRICAL NULL METHOD

FSGS Recurrence Collaboration: Report of a Symposium.

Attenuated kidney oxidative metabolism in young adults with type 1 diabetes

RESOLVE: Recurrence Posttransplant Observational Study in Focal Segmental Glomerulosclerosis and Minimal Change Disease

Identification of Kidney Cell Types in Single-Cell RNA Sequencing and Single-Nucleus RNA Sequencing Data Using Machine-Learning Algorithms

SGLT2 inhibitors mitigate kidney tubular metabolic and mTORC1 perturbations in youth-onset type 2 diabetes

Genome-wide Association Study for AKI.

Cultured Renal Proximal Tubular Epithelial Cells Resemble a Stressed/Damaged Kidney While Supporting BK Virus Infection

WCN23-0472 UNDERSTANDING THE MECHANISM OF SGLT2 INHIBITOR IN YOUNG PERSONS WITH TYPE 2 DIABETES USING SINGLE-CELL RNA-SEQ DATA

WCN23-0761 SGLT2 INHIBITOR TREATMENT MAY ENHANCE KIDNEY OXYGENATION AND ATTENUATE HIF1A EXPRESSION IN YOUNG PERSONS WITH TYPE 2 DIABETES

Cannabinoid Signaling in the Diabetic Proximal Tubule: Of Mice and Men

Developing a Healthy Lifestyle Program for Recent Kidney Transplant Recipients

An atlas of healthy and injured cell states and niches in the human kidney

A reference tissue atlas for the human kidney

Gene Expression Sets and Renal Profiling from the Rain (Renal AL Amyloid Involvement and NEOD00) Trial

Glomerular endothelial cell-podocyte stresses and crosstalk in structurally normal kidney transplants

Collaborators (11)

Paul Palevsky

Guanshi Zhang

James M. Pipas

Jonathan Segal

Lihua Li

Jens Hansen

Matthew Cusick

Ulysses Balis

Markus Bitzer

Tara Sigdel

Steven Menez

Make your next move.